Company Profile
Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. It operates through two segments Hospital Operations; and Other Businesses That Support Hospital Business. The company operates hospitals under the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital, and Royal Hospital Group names; and BDMS Wellness Clinic. It also offers medical laboratory, holistic clinical wellness, accounting, technology and information, training, investment and asset management, air transportation, skin and aesthetics telemedicine, and genomic medicine services; operates hotels and pharmacies; provides health insurance and insurance brokerage services; retails medicine and pharmaceutical products; and distributes health products and cosmetic products, as well as facility management services. In addition, the company is involved in production and distribution of medicines, pharmaceutical products, medical equipment, and saline; real estate; e-commerce; and investment and operation of BDMS silver wellness and residence products. Bangkok Dusit Medical Services Public Company Limited was founded in 1969 and is headquartered in Bangkok, Thailand.
Latest News
Apple Makes Privacy Central to Smart Glasses Push
BMO Capital Adjusts Price Target on Healthpeak Properties to $25 From $24, Maintains Outperform Rating
Argus Adjusts Price Target on Chubb to $396 From $360, Maintains Buy Rating
Loop Capital Adjusts Price Target on American Express to $386 From $389, Maintains Buy Rating
BMO Capital Adjusts Price Target on NextEra Energy to $96 From $94, Maintains Outperform Rating
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Website | https://www.bdms.co.th |
| Market Cap | 301.95B |
| Trailing P/E | 19.19 |
| Dividend Rate | 0.8 |
| Dividend Yield | 3.51% |
| Trailing Annual Div. Rate | 1 |
| Trailing Annual Div. Yield | 5.29% |
| Trailing EPS | 0.99 |
| Book Value | 6.93 |
| Price-to-Book | 2.74 |
| Enterprise-to-Revenue | 2.75 |
| Enterprise-to-EBITDA | 11.87 |
| Ex-Dividend Date | 03/10/2026 |
| Earnings Date | |
| Earnings Call Date | |
| Revenue Average | 27.16B |
| Revenue Low | 26.98B |
| Revenue High | 27.46B |